Tessa Straatmijer

8PUBLICATIONS
18CO-AUTHORS
Medical biochemistry - lipidsImmunogenetics (incl. genetic immunology)Rheumatology and arthritisCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 28, 2026
New therapeutic options for metabolic-associated steatotic liver disease.

|Apr 16, 2025
Obesity Is Associated with Inferior Clinical Treatment Outcomes in Inflammatory Bowel Disease: A Nationwide Dutch Registry Study.

Dorien Oomkens, Zlatan Mujagic, Annemarie de Vries

|Mar 15, 2023
Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn's Disease.

Tessa Straatmijer, Vince B C Biemans, Dirk Jan A R Moes

|Oct 25, 2022
Effectiveness and safety of tofacitinib for ulcerative colitis: two-year results of the ICC Registry.

Tessa Straatmijer, Fiona D M van Schaik, Alexander G L Bodelier

|Jul 23, 2022
Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases.

Adriaan Volkers, Tessa Straatmijer, Marjolijn Duijvestein

|Apr 28, 2021
Ustekinuma b for Crohn's Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study.

Tessa Straatmijer, Vince B C Biemans, Frank Hoentjen

Pageof 2

Frequent Collaborators

2 joint publications

Vince B C Biemans

2 joint publications

Adriaan Volkers

1 joint publications

Marieke Pierik

1 joint publications

Jeroen Maljaars